Form and Function in Flux: Molecular Ensembles from Structure to Therapy
- 1ACCESS Health International, 3489 Leafy Way, Miami, FL 33133, USA
- 2Department of Regenerative Medicine, Feinstein Institutes for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA
Abstract
Molecular structure, revealed by crystallography, cryo-electron microscopy, imaging, and prediction, remains foundational to biology and drug design, yet function also depends on how structures flex, adapt, and interact. Proteins and RNA populate alternative conformations and binding states, while chromatin, membranes, glycans, metabolites, water, ions, and biominerals vary in composition and organization. This narrative review treats form and function as interdependent properties of molecular ensembles: structure constrains which states are accessible, whereas regulatory inputs, partners, and cellular environments determine which states are occupied, exchanged, and used. Without assuming a shared physical mechanism, we compare these systems and propose a cross-class evidence map that links each claimed state variable to its regulatory input, matched measurement, causal test, and organismal or clinical outcome. Examples from cancer, neurodegeneration, infection, and metabolic disease show how specific states become dysregulated, and why restored binding, assembly, or imaging readouts need not indicate functional recovery. Therapies are compared by primary mode of action—direct state modulation, target-abundance reduction, or genetic and RNA-level correction—with clinical successes, failures, and safety limits reported separately. The synthesis identifies where measurement methods must advance to resolve interrelated ensembles in native contexts and to determine when targeting them yields meaningful patient benefit.
Related
- Interfacial Water as a Chemically Tunable Medium: From Molecular Structure to Materials Function
- mdRNAcat: A Molecular Dynamics RNA Catalog of REST2 Conformational Ensembles
- MERGE-RNA: a physics-based model to predict RNA secondary structure ensembles with chemical probing
- Autofocusing molecular simulations for integrative structural biology of broad conformational ensembles
- Illuminating the Diversity of Electrical Synapse Form and Function
BibTeX
@article{patarca2026form,
title = {{Form and Function in Flux: Molecular Ensembles from Structure to Therapy}},
author = {Roberto Patarca and William Alan Haseltine},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272210192},
url = {https://www.mdpi.com/1422-0067/27/22/10192},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Form and Function in Flux: Molecular Ensembles from Structure to Therapy
AU - Roberto Patarca
AU - William Alan Haseltine
PY - 2026
DA - 2026/11/13
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272210192
UR - https://www.mdpi.com/1422-0067/27/22/10192
AB - Molecular structure, revealed by crystallography, cryo-electron microscopy, imaging, and prediction, remains foundational to biology and drug design, yet function also depends on how structures flex, adapt, and interact. Proteins and RNA populate alternative conformations and binding states, while chromatin, membranes, glycans, metabolites, water, ions, and biominerals vary in composition and organization. This narrative review treats form and function as interdependent properties of molecular ensembles: structure constrains which states are accessible, whereas regulatory inputs, partners, and cellular environments determine which states are occupied, exchanged, and used. Without assuming a shared physical mechanism, we compare these systems and propose a cross-class evidence map that links each claimed state variable to its regulatory input, matched measurement, causal test, and organismal or clinical outcome. Examples from cancer, neurodegeneration, infection, and metabolic disease show how specific states become dysregulated, and why restored binding, assembly, or imaging readouts need not indicate functional recovery. Therapies are compared by primary mode of action—direct state modulation, target-abundance reduction, or genetic and RNA-level correction—with clinical successes, failures, and safety limits reported separately. The synthesis identifies where measurement methods must advance to resolve interrelated ensembles in native contexts and to determine when targeting them yields meaningful patient benefit.
SN - 1422-0067
ER -